Metabolic switch and epithelial-mesenchymal transition cooperate to regulate pluripotency.
Hao SunXiao YangLining LiangMengdan ZhangYuan LiJinlong ChenFuhui WangTingting YangFei MengXiaowei LaiChangpeng LiJingcai HeMeiai HeQiaoran XuQian LiLilong LinDuan-Qing PeiHui ZhengPublished in: The EMBO journal (2020)
Both metabolic switch from oxidative phosphorylation to glycolysis (OGS) and epithelial-mesenchymal transition (EMT) promote cellular reprogramming at early stages. However, their connections have not been elucidated. Here, when a chemically defined medium was used to induce early EMT during mouse reprogramming, a facilitated OGS was also observed at the same time. Additional investigations suggested that the two events formed a positive feedback loop via transcriptional activation, cooperated to upregulate epigenetic factors such as Bmi1, Ctcf, Ezh2, Kdm2b, and Wdr5, and accelerated pluripotency induction at the early stage. However, at late stages, by over-inducing glycolysis and preventing the necessary mesenchymal-epithelial transition, the two events trapped the cells at a new pluripotency state between naïve and primed states and inhibited further reprogramming toward the naïve state. In addition, the pluripotent stem cells at the new state have high similarity to epiblasts from E4.5 and E5.5 embryos, and have distinct characteristics from the previously reported epiblast-like or formative states. Therefore, the time-dependent cooperation between OGS and EMT in regulating pluripotency should extend our understanding of related fields.
Keyphrases
- epithelial mesenchymal transition
- embryonic stem cells
- transforming growth factor
- early stage
- signaling pathway
- cell fate
- induced apoptosis
- gene expression
- pluripotent stem cells
- stem cells
- transcription factor
- body mass index
- bone marrow
- cell cycle arrest
- oxidative stress
- cell proliferation
- sentinel lymph node
- weight gain
- long noncoding rna
- cell death
- protein kinase
- weight loss
- drug induced
- locally advanced